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symptoms were recognised by patients using similar language
as symptom descriptors. No additional symptoms were offered.
Frequency, severity and predictability of symptom occurrence
were considered to be relevant features of symptoms. Shortness
of breath was reported to be the main symptom to have an
impact on patients’ lives. Severity and frequency of symptoms
affected the level of impact on a patient’s life. Patients reported
that the main impact of symptoms is the need to use their rescue
medication and limitations on physical activity. Sleep disturbance
and the need to adjust their life to avoid factors that they know
trigger asthma worsenings were also reported. CONCLUSIONS:
The four symptoms were conﬁrmed along with consistency of
terminology indicating homogeneity of understanding amongst
the patients. Findings suggest it is relevant to measure frequency
and severity of symptoms. Symptoms impact a patient’s life in a
number of ways.
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OBJECTIVES: Understanding and identifying impaired quality
of life (QoL) is now recognised as an important component of
asthma and COPD management. The aim of the study was to
assess which factors affect patient’s QoL, to examin the relation-
ship between these factors (outcomes) and the QoL data; as well
as to evaluate the possible differences between patients with
and without a signiﬁcant high level of anxiety/ depression.
METHODS: A total of 130 patients (70 asthmatics and 60
COPD) were analysed in the study. Patients were asked to
respond to self administered questionnaires: the St George’s Res-
piratory Questionnaire (SGRQ), the EQ-5D, the Beck depression
scale and a range of questions concerning smoking habits, inhaler
use technique, disease management. Data was analysed by using
Statistical Programme Package for Social Sciences statistical soft-
ware 15.0; linear multiple regression and factor analysis were
conducted. RESULTS: We found at 5% signiﬁcance level notable
correlation between the SGRQ score and EQ-5D -0,648; Beck
score 0,690; FEV1 0,522; age 0.505. We implied a linear multiple
regression model, where the dependent variable was the SGRQ
score and the independent variables were: FEV1 and the Beck
score (R2 = 0.48; P = 0.001) in model 1; and disease severity/
hospitalisation and Beck score (R2 = 0.55; P = 0.005) in model 2.
In the factor analysis the loading of the 9 outcomes (age, sex,
anxiety/depression, smoking status, lung function, disease
severity/hospitalization, inhaler use technique, disease manage-
ment) onto 5 identiﬁable factors suggest that, patients actual
health status is mainly affected by age, sex, the Beck scale
(depression) and smoking. CONCLUSIONS: Our results suggest
that however correlation is moderately strong between QoL and
clinical outcomes, patients QoL impairment is mainly attribut-
able to depression status, inhalation technique and smoking
status. All of these can be improved by adequate, regular patient
education, resulting in optimal asthma and COPD control.
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OBJECTIVES: To compare generic (EQ-5D, SF-12) and disease-
speciﬁc (SGRQ) instruments for measuring the impact of severe
acute exacerbations on quality of life (QoL) in patients with
chronic obstructive pulmonary disease (COPD) treated in hospi-
tal with regard to acceptance, ceiling effects, sensitivity to change
and discrimination between groups with different disease severi-
ties. METHODS: Patients treated for acute exacerbations
of COPD in the Asklepios-Fachkliniken München-Gauting,
Germany, were asked to complete the questionnaire at admission
and again before discharge. Information about patients’ age, sex,
smoking status and disease severity according to GOLD class-
iﬁcation was collected and EQ-5D, SF-12 and SGRQ were
answered as self-administered questionnaires. Utility values were
calculated for the EQ-5D and the SF-12 based on published
utility weights. For the SGRQ, impact, symptom, activity and
total scores were calculated. T-tests were conducted to compare
proportions of missing values and sensitivity to change. The
impact of different GOLD stages on QoL was assessed using
linear mixed models. RESULTS: Preliminary analyses showed
the highest acceptance for the EQ-5D, with the lowest percentage
of missing utility values. No ceiling or ﬂoor effects occurred for
the SF-12, whereas the SGRQ showed ﬂoor effects particularly
for the dimension activity at both time points. Ceiling effects
occurred for the EQ-5D at discharge. Sensitivity to change was
highest for EQ-5D and SGRQ, whereas only minor changes were
observed for the SF-12. However, differences between GOLD
stages after adjusting for age and sex were best captured by the
SF-12. CONCLUSIONS: The main problem of the SF-12 and
the SGRQ is the high proportion of missing values although the
former differentiates best between GOLD stages. The EQ-5D
seems well suited for this patient group, yet ceiling effects pose a
problem with this severe disease.
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OBJECTIVES: Current asthma treatments according to GINA
2007 guidelines have been designed to offer a better asthma
control and thereby optimal patient well-being. This study aims
to demonstrate their impact on a Greek asthmatic population.
METHODS: A total of 747 patients were included in the study.
614 were included in the analysis (261 males / 353 females, mean
age 49/46 years). They were visiting their primary care physician
(52% general practitioners, 48% specialists) for their asthma. All
patients had moderate to severe asthma and were treated with a
LABA/ICS combination, both for maintenance and relief
(budesonide/formoterol via Turbuhaler® according to the
approved dosage), according to current clinical practice for at
least one month prior to their enrollment. They completed a
package of questionnaires; the Asthma Control Questionnaire
(ACQ), the Asthma Quality of Life Questionnaire (AQLQ), and
questions on treatment satisfaction. RESULTS: Eighty-ﬁve per-
cent of the patients perceived their asthma as controlled. Of
these patients, 67% were well controlled or partly controlled
(WCoPC) (ACQ < = 1.5), 33% were uncontrolled/poorly con-
trolled (UNPC) ACQ > 1.5. Almost half of all patients were on
low maintenance doses (1 inhalation bid) and the other half
on high maintenance doses (2 inhalations bid). 55% of patients
on low maintenance doses were WCoPC compared 40% on high
maintenance doses. Patients with WCoPC reported a good
health-related quality of life (average AQLQ = 6.4), which were
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